Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bacillus Calmette-Guerin Vaccines
Study results from M.M. Ho and colleagues update understanding of Bacillus calmette-guerin vaccines
October 8th, 2008
Researchers detail in 'Report of an international collaborative study to establish the suitability of using modified ATP assay for viable count of BCG vaccine,' new data in Bacillus calmette-guerin. According to a study from Potters Bar, the United Kingdom, "As part of the World Health Organisation (WHO) initiative to update the current requirements for BCG vaccine a collaborative study was carried out to establish the robustness, reproducibility and the suitability of the modified ATP assay. This assay was developed by Statens Serum Institut, Denmark, as a potential replacement of the method for detection of viable counts of BCG vaccine which is routinely used as a quality control test...
Source: Vaccine Weekly (2008-10-08)
|
